CD8A and lymphoid neoplasm: The current 2017 WHO classification of lymphoid neoplasms includes the severe distinct disease entities cytotoxic T‐ and NK‐cell lymphomas, which are both characterized by constant expression of cytotoxic molecules, as well as frequent EBV association, CD8 positivity, TCRγδ phenotype, and predilection for certain anatomical sites.16